Clinical Trial Update: A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED) [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating AZR-MD-001 in Meibomian Gland Dysfunction and evaporative dry eye disease; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Meibomian Gland Dysfunction

Drugs mentioned

• AZR-MD-001

Snippet

Sponsor: Azura Ophthalmics | Conditions: Meibomian Gland Dysfunction, Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2024-02-28